IT1232273B - Anticorpo umano monoclonale ed ibridoma che produce il medesimo - Google Patents

Anticorpo umano monoclonale ed ibridoma che produce il medesimo

Info

Publication number
IT1232273B
IT1232273B IT8967343A IT6734389A IT1232273B IT 1232273 B IT1232273 B IT 1232273B IT 8967343 A IT8967343 A IT 8967343A IT 6734389 A IT6734389 A IT 6734389A IT 1232273 B IT1232273 B IT 1232273B
Authority
IT
Italy
Prior art keywords
hybridome
produces
same
human antibody
monoclonal human
Prior art date
Application number
IT8967343A
Other languages
English (en)
Italian (it)
Other versions
IT8967343A0 (it
Inventor
Shinichi Ohtsuka Hirosh Yokota
Hiroshi Noguchi Hiroshi Ochi
Masazumi Terashima
Masuhiro Kato
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of IT8967343A0 publication Critical patent/IT8967343A0/it
Application granted granted Critical
Publication of IT1232273B publication Critical patent/IT1232273B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IT8967343A 1988-05-10 1989-05-09 Anticorpo umano monoclonale ed ibridoma che produce il medesimo IT1232273B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11447388 1988-05-10

Publications (2)

Publication Number Publication Date
IT8967343A0 IT8967343A0 (it) 1989-05-09
IT1232273B true IT1232273B (it) 1992-01-28

Family

ID=14638614

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8967343A IT1232273B (it) 1988-05-10 1989-05-09 Anticorpo umano monoclonale ed ibridoma che produce il medesimo

Country Status (10)

Country Link
US (1) US5252480A (OSRAM)
EP (1) EP0341684B1 (OSRAM)
JP (1) JP2645665B2 (OSRAM)
AT (1) AT397803B (OSRAM)
BE (1) BE1001964A4 (OSRAM)
CH (1) CH681012A5 (OSRAM)
DE (1) DE68920624T2 (OSRAM)
FR (1) FR2631239B1 (OSRAM)
GB (1) GB2218703B (OSRAM)
IT (1) IT1232273B (OSRAM)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521085A (en) * 1986-12-15 1996-05-28 Mitsui Toatsu Chemicals, Inc. Transformed cell lines producing human monoclonal antibodies specific for Pseudomonas aeruginosa serotypes
EP0382031A3 (en) * 1989-02-10 1991-06-26 Miles Inc. Monoclonal antibodies in immune serum globulin
JPH02283294A (ja) * 1989-04-24 1990-11-20 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
JPH04211393A (ja) * 1990-02-08 1992-08-03 Sumitomo Pharmaceut Co Ltd ヒトモノクローナル抗体及びそれを有効成分とする緑膿菌感染症治療剤
GB9105292D0 (en) * 1991-03-13 1991-04-24 Sandoz Ltd Improvements in or relating to organic compounds
US5648660A (en) * 1996-01-05 1997-07-15 Sterling Diagnostic Imaging, Inc. Method and apparatus for reducing noise in a radiation capture device
US6197582B1 (en) 1998-03-18 2001-03-06 The Trustees Of Columbia University In The City Of New York Development of human monoclonal antibodies and uses thereof
DK1520588T3 (en) 1998-07-13 2015-03-23 Univ Texas Use of antibodies to aminophospholipids for cancer treatment
US7060802B1 (en) * 2000-09-18 2006-06-13 The Trustees Of Columbia University In The City Of New York Tumor-associated marker
ATE442862T2 (de) * 2000-10-12 2009-10-15 Genentech Inc Niederviskose konzentrierte proteinformulierungen
US8703126B2 (en) 2000-10-12 2014-04-22 Genentech, Inc. Reduced-viscosity concentrated protein formulations
US20040191243A1 (en) * 2002-12-13 2004-09-30 Bei Chen System and method for stabilizing antibodies with histidine
US20050158303A1 (en) * 2003-04-04 2005-07-21 Genentech, Inc. Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations
BRPI0403964B8 (pt) * 2003-04-04 2021-05-25 Genentech Inc formulações líquidas estáveis, artigo manufaturado e uso dessas formulações para o tratamento de disfunção mediada por ige
FR2859725B1 (fr) * 2003-09-16 2006-03-10 Neovacs Procede a haut rendement pour l'obtention d'anticorps humains neutralisant l'activite biologique d'une cytokine humaine
US20060051347A1 (en) 2004-09-09 2006-03-09 Winter Charles M Process for concentration of antibodies and therapeutic products thereof
AU2010221156A1 (en) * 2009-03-06 2011-09-22 Genentech, Inc. Antibody formulation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3484773D1 (de) * 1983-05-06 1991-08-08 Velos Group Mit endotoxinkern reaktionsfaehige monoklonale antikoerper.
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
WO1986003754A1 (en) * 1984-12-26 1986-07-03 Teijin Limited Anti-pseudomonas aeruginosa human monoclonal antibody
AU584690B2 (en) * 1985-03-11 1989-06-01 Teijin Limited E87ag antigen of pseudomonas aeruginosa, monoclonal antibody against it, and hybridoma
US4777136A (en) * 1985-09-27 1988-10-11 The Regents Of The University Of California Monoclonal antibody reactive with Pseudomonas Aeruginosa
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
JPS62215131A (ja) * 1986-03-13 1987-09-21 Kawasaki Heavy Ind Ltd 遠心クラツチ
EP0256713A3 (en) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutic human antipseudomonas aeruginosa antibodies
WO1988008135A1 (en) * 1987-04-10 1988-10-20 Xoma Corporation Human monoclonal antibodies binding determinants of gram negative bacteria

Also Published As

Publication number Publication date
FR2631239A1 (fr) 1989-11-17
EP0341684A3 (en) 1990-01-17
ATA111789A (de) 1993-11-15
FR2631239B1 (fr) 1994-05-27
CH681012A5 (OSRAM) 1992-12-31
DE68920624D1 (de) 1995-03-02
US5252480A (en) 1993-10-12
JPH0284197A (ja) 1990-03-26
AT397803B (de) 1994-07-25
EP0341684A2 (en) 1989-11-15
GB2218703A (en) 1989-11-22
DE68920624T2 (de) 1995-07-27
GB2218703B (en) 1992-10-28
JP2645665B2 (ja) 1997-08-25
EP0341684B1 (en) 1995-01-18
BE1001964A4 (fr) 1990-04-24
IT8967343A0 (it) 1989-05-09
GB8910395D0 (en) 1989-06-21

Similar Documents

Publication Publication Date Title
BR1100580A (pt) Composto e complexo
DK666389D0 (da) Monoklonalt antistof
FR2633803B1 (fr) Agrotextile composite et ses applications
NO921863L (no) Antistoffer og anvendelse derav
IL88145A0 (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
BR8906488A (pt) Gel desodorante e antitranspirante
IT1232273B (it) Anticorpo umano monoclonale ed ibridoma che produce il medesimo
DK40989A (da) Dionforbindelser
DK245188A (da) Stoej- og vibrationsdaempende materialer
IT8921590A0 (it) Procedimento e dispositivo di formatura.
DK190889A (da) Antigen
BR8903389A (pt) Conjunto moto-redutor e utilizacao do mesmo
FI945485L (fi) Monoklonaaliset vasta-aineet ja niiden käyttö
FI911510A7 (fi) Hydroksimetyyli-indolitsidiinejä ja -kinolitsidiinejä
EP0229107A4 (en) PROTECTIVE HUMAN MONOCLONAL ANTIBODIES TO -i(PSEUDOMONAS AERUGINOSA) EXOTOXIN A.
FI952108A7 (fi) Fibronnektiiniä sitova proteiini sekä sen valmistaminen
FI894552A0 (fi) Anordning i gasregulator.
DK32689A (da) Teicoplaninhydrazider samt fremstilling og anvendelse deraf
DK413389D0 (da) Monoklonale antistoffer
ATE99332T1 (de) Monoklonale antikoerper gegen menschliche interleukin-4 und die sie erzeugenden hybridomen.
IT8812575A0 (it) Parallelografo e tecnigrafo
TR23793A (tr) Payplarin ve gecitlerin kaplanmasinda ypilan isla- hat.
DK220688D0 (da) Monoklonalt antistof
IT1194260B (it) Linfochine e anticorpi monoclonali umani
IT1219146B (it) Machinetta tritaprezzemolo ed aglio

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970530